Diagnos Laboratorium Utama PT Tbk (DGNS) — Financial Flexibility Index
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Financial Flexibility Index of 0.04x as of June 2025. Free cash flow of Rp4.16 Billion (operating CF Rp1.52 Billion minus capex Rp2.64 Billion) represents 0% of total liabilities (Rp110.07 Billion). Also explore Diagnos Laboratorium Utama PT Tbk (DGNS) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Diagnos Laboratorium Utama PT Tbk Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Diagnos Laboratorium Utama PT Tbk across 8 annual periods. Check DGNS strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Diagnos Laboratorium Utama PT Tbk (2017–2024)
Year-by-year free cash flow to debt coverage for Diagnos Laboratorium Utama PT Tbk. For the full company profile including market capitalisation, see Diagnos Laboratorium Utama PT Tbk stock valuation.
| Year | Flexibility Index | Free Cash Flow (IDR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.68x | Rp70.69 Billion | Rp27.30 Billion | Rp103.89 Billion | ▲ +0.2% |
| 2023 | 0.68x | Rp51.51 Billion | Rp13.18 Billion | Rp75.88 Billion | ▼ -30.5% |
| 2022 | 0.98x | Rp28.84 Billion | Rp-6.02 Billion | Rp29.51 Billion | ▼ -69.0% |
| 2021 | 3.15x | Rp126.72 Billion | Rp58.87 Billion | Rp40.18 Billion | ▲ +229.3% |
| 2020 | 0.96x | Rp32.09 Billion | Rp26.23 Billion | Rp33.51 Billion | ▼ -12.6% |
| 2019 | 1.10x | Rp13.98 Billion | Rp11.20 Billion | Rp12.76 Billion | ▼ -0.5% |
| 2018 | 1.10x | Rp12.30 Billion | Rp8.47 Billion | Rp11.17 Billion | ▲ +1609.3% |
| 2017 | -0.07x | Rp-384.52 Million | Rp-712.00 Million | Rp5.27 Billion | — |